Nathan Erdmann, MD, PhD
Therapeutic Discovery in the Midst of a Global Pandemic

As the historic and sobering COVID-19 pandemic persists across Alabama, the US, and the rest of the world, Dr. Erdmann will provide updates and perspective on therapeutic interventions and how they have evolved in recent months.

Nathan Erdmann, MD, PhD
Asst. Professor, Div. of Infectious Diseases,
University of Alabama at Birmingham
Assoc. Scientist, UAB Center for AIDS Research

August 25, 2020

Play Video

About the Presenter

Dr. Erdmann completed his MD/PhD at the University of Nebraska Medical Center. His research focused on understanding the mechanisms of HIV-mediated inflammation and neurotoxicity. He then joined the ABIM Research Pathway at UAB, completing his internship and residency before joining the Division of Infectious Disease as a fellow. He is now an Instructor of Medicine, and his research focuses on T cell responses in HIV under the mentorship of Dr. Paul Goepfert. Dr. Erdmann has described the role of CD4 T cells in controlling HIV infection through cytolytic activities.